uniQure N.V.
QURE
Market Cap$699.98M
Close$
$-2.46
119.2% downside
Current Fair Value
119.2% downsideOvervalued by 119.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $699.98 Million |
|---|---|
| Enterprise Value | $607.11 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.92 |
| Beta | 0.1 |
| Outstanding Shares | 48,840,666 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.61 |
|---|---|
| PEG | 5.17 |
| Price to Sales | - |
| Price to Book Ratio | -12.81 |
| Enterprise Value to Revenue | 21.24 |
| Enterprise Value to EBIT | -3.08 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | -9.78 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About uniQure N.V.
uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to tr...